Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Becton Dickinson And Company (BDX)
NYSE:BDX
Holding BDX?
Track your performance easily
BDX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$218.75 - $248.42
Previous CloseN/A
Volume443.35K
Average Volume (3M)2.20M
Market Cap
$68.38B
Enterprise Value$88.68B
Total Cash (Recent Filing)$14.20B
Total Debt (Recent Filing)$18.67B
Price to Earnings (P/E)39.7
Beta0.39
Next Earnings
Feb 06, 2025EPS Estimate
2.99Last Dividend Ex-Date
Dec 09, 2024Dividend Yield1.65%
Share Statistics
EPS (TTM)5.94
Shares Outstanding290,007,780
10 Day Avg. Volume2,152,329
30 Day Avg. Volume2,198,267
Standard Deviation0.06
R-Squared0.14
Alpha-0.00486
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.33
Price to Cash Flow (P/CF)14.30
P/FCF Ratio15.20
Enterprise Value/Market Cap1.30
Enterprise Value/Revenue4.39
Enterprise Value/Gross Profit9.72
Enterprise Value/Ebitda18.99
Forecast
1Y Price Target
$272.00Price Target Upside15.11% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
Becton Dickinson News
PremiumCompany Announcements
Becton Dickinson Appoints New Chief Accounting Officer
PremiumCompany Announcements
Becton, Dickinson Reports Strong Fiscal 2024 ResultsBulls Say, Bears Say
Bulls Say
Financial PerformanceBDX finished with organic revenue growth of 6.2% and EPS up 11.4% from last year, beating estimates on top and bottom lines.
Portfolio ManagementAnalyst sees potential for value creation through portfolio management following recent acquisitions and spin-offs.
Product PipelineBDX has an attractive multi-product pipeline with several key launches planned for the next calendar year.
Bears Say
Financial PerformanceThe EPS guide was a disappointment after higher expectations were set three months ago.
Market DynamicsBD Lifesciences' top-line is pressured by market dynamics including challenges in China.
Sales Growth GuidanceBDX introduced FY25 guidance of +4.0-4.5% organic growth, which is behind MSe/Cons of (+5.8% and +5.2%).
---
Ownership Overview
0.13% Insiders
24.78% Mutual Funds
0.57% Other Institutional Investors
53.55% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Macro & PoliticalRisks related to catastrophic events or geopolitical conditions that may disrupt the company’s business
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BDX FAQ
What was Becton Dickinson And Company’s price range in the past 12 months?
Becton Dickinson And Company lowest stock price was $218.75 and its highest was $248.42 in the past 12 months.
What is Becton Dickinson And Company’s market cap?
Becton Dickinson And Company’s market cap is $68.38B.
When is Becton Dickinson And Company’s upcoming earnings report date?
Becton Dickinson And Company’s upcoming earnings report date is Feb 06, 2025 which is in 19 days.
How were Becton Dickinson And Company’s earnings last quarter?
Becton Dickinson And Company released its earnings results on Nov 07, 2024. The company reported $3.81 earnings per share for the quarter, beating the consensus estimate of $3.768 by $0.042.
Is Becton Dickinson And Company overvalued?
According to Wall Street analysts Becton Dickinson And Company’s price is currently Undervalued.
Does Becton Dickinson And Company pay dividends?
Becton Dickinson And Company pays a Quarterly dividend of $3.886 which represents an annual dividend yield of 1.65%. See more information on Becton Dickinson And Company dividends here
What is Becton Dickinson And Company’s EPS estimate?
Becton Dickinson And Company’s EPS estimate is 2.99.
How many shares outstanding does Becton Dickinson And Company have?
Becton Dickinson And Company has 290,007,780 shares outstanding.
What happened to Becton Dickinson And Company’s price movement after its last earnings report?
Becton Dickinson And Company reported an EPS of $3.81 in its last earnings report, beating expectations of $3.768. Following the earnings report the stock price went down -5.391%.
Which hedge fund is a major shareholder of Becton Dickinson And Company?
Among the largest hedge funds holding Becton Dickinson And Company’s share is Generation Investment Management LLP. It holds Becton Dickinson And Company’s shares valued at 1B.
---
Becton Dickinson Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$272.00 (15.11% Upside)
$272.00 (15.11% Upside)
Blogger Sentiment
Bullish
BDX Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 917.1K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.3M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.0%
Last 30 Days ▲ 8.7%
Last 30 Days ▲ 8.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
2.25%
12-Months-Change
Fundamentals
Return on Equity
6.68%
Trailing 12-Months
Asset Growth
8.54%
Trailing 12-Months
Company Description
Becton Dickinson And Company
Founded in 1897, Becton, Dickinson & Co. is a New Jersey-based medical technology company. The company develops, manufactures and sells medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional.
---
BDX Company Deck
---
BDX Earnings Call
Q4 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view with strong growth in key segments and operational improvements, tempered by challenges in China and bioscience markets. Overall, BD is well-positioned for FY '25 with a focus on innovation and strategic growth opportunities.Read More>---
BDX Revenue Breakdown
57.80% U.S.
21.82% EMEA
14.40% Greater Asia
5.98% Other
---
BDX Stock 12 Month Forecast
Average Price Target
$272.00
▲(15.11% Upside)
Technical Analysis
Baxter International
―
Medtronic
―
Stryker
―
Zimmer Biomet Holdings
―
Edwards Lifesciences
―
Boston Scientific
―
Best Analysts Covering BDX
1 Year
1 Year Success Rate
8/12 ratings generated profit
1 Year Average Return
-0.63%
reiterated a buy rating 3 months ago
Copying Jason Bednar's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of -0.63% per trade.
---